Eurican L Ireland - English - HPRA (Health Products Regulatory Authority)

eurican l

boehringer ingelheim vetmedica gmbh - inactivated leptospira canicola; inactivated leptospira icterohaemorrhagiae - suspension for injection - . - leptospira

VANGUARD LEPTO-CI Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard lepto-ci

pfizer healthcare ireland - leptospira canicola inactivated leptospira icterohaemorrhagiae inactivated - solution for injection - canine - immunological - inactivated vaccine

VANGUARD 7 Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard 7

pfizer healthcare ireland - canine distemper virus strain n-cdv canine adenovirus, strain manhattan, live attenuated canine parainfluenza, strain nl-cpi-5, live attenuated canine parvovirus, strain nl-35-d, live attenuated leptospira icterohaemorrhagiae inactivated leptospira canicola inactivated - lyophilisate and solvent for solution for injection - canine - immunological - mixed vaccine (live and inactivated)

VANGUARD 7 Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard 7

zoetis ireland limited - canine distemper virus strain n-cdv (live, attenuated), canine adenovirus type 2 virus, strain manhattan (live, attenuated), canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated), canine parvovirus, strain nl-35-d, live attenuated, leptospira icterohaemorrhagiae inactivated, leptospira canicola inactivated - lyophilisate and solvent for solution for injection - %v/v - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - mixed vaccine (live and inactivated)

Recombitek C6 Each 1.0 mL dose of vaccine contains the following through expiration: Active Ingredients: Canine Distemper, Canarypox Vector .............................................. ≥106.4 TCID50 Canine Adenovirus Type 2 ............................................................. ≥104.3 TCID50 Canine Parainfluenza .................................................................... ≥103.9 TCID50 Canine Parvovirus ........................................................................ ≥103.3 FAID50 Leptospira canicola ....................................................... ≥40 nephelometric units Leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *TCID-Tissue Culture Infective Dose **FAID. Fluorescent Antibody Infective Dose ***NTU- Nephelometric Units Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6 each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units

Recombitek C6/CV 1 dose of 1 ml vaccine contains: Lyophilized: Canine Distemper, Canarypox Vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 TCID50 Canine Adenovirus Type 2, Toronto A/26/61 strain, at least. . . . . . . . . . . . 104.3 TCID50 Canine Parainfluenza virus, D-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 TCID50 Canine Coronavirus, K-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 TCID50 Canine Parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 FAID50 Liquid: Leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 NU Leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 NU Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6/cv 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus (ccv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu

PROTECH C2I CANINE CORONAVIRUS & LEPTOSPIRA COPENHAGENI KILLED VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

protech c2i canine coronavirus & leptospira copenhageni killed vaccine

boehringer ingelheim animal health australia pty. ltd. - leptospira icterohaemorrhagiae antigen; canine coronavirus vaccine - antigen - misc. vaccines or anti sera - leptospira icterohaemorrhagiae antigen vaccine-antigen active 1.0 rp; canine coronavirus vaccine - antigen vaccine-viral active 1.62 rp - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parainfluenza | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus

VANGUARD CPV-L Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard cpv-l

pfizer healthcare ireland - canine parvovirus, strain nl-35-d, live attenuated leptospira canicola inactivated leptospira icterohaemorrhagiae inactivated - solution for injection - canine - immunological - mixed vaccine (live and inactivated)

FIXR Parvo Lepto inj. emuls. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fixr parvo lepto inj. emuls. i.m. vial

kernfarm b.v. - leptospira interrogans serogroup australis (inactivated) ; leptospira interrogans serogroup pomona (inactivated) ; porcine parvovirus (inactivated) ; leptospira kirschneri serovar gryppotyphosa (inactivated) ; leptospira interrogans serovar icterohaemorrhagiae (inactivated) ; leptospira interrogans serogroup sejroe (inactivated) ; leptospira interrogans serogroup canicola (inactivated) - emulsion for injection - porcine parvovirus; leptospira interrogans australis; leptospira interrogans canicola; leptospira interrogans grippotyphosa; leptospira interrogans icterohaemorrhagiae; leptospira interrogans pomona; leptospira interrogans sejroe - inactivated viral and inactivated bacterial vaccines - pig

PORCILIS ERY+PARVO+LEPTO SUSPENSION FOR INJECTION FOR PIGS Ireland - English - HPRA (Health Products Regulatory Authority)

porcilis ery+parvo+lepto suspension for injection for pigs

intervet international bv - e.rhusiopathiae strain m2, porcine parvo virus, leptospira canicola, leptospira icterohaemorrhagiae, leptospira australis, leptospira grippotyphosa, leptospira pomona, leptospira tarassovi - suspension for injection - inactivated porcine parvovirus vaccine + inactivated erysipelothrix vaccine + inactivated leptospira - porcine - immunological - inactivated vaccine